Latest News about ATAI
Recent news which mentions ATAI
Benzinga's Top Ratings Upgrades, Downgrades For September 1, 2021
September 01, 2021
From Benzinga
21 Stocks Moving in Wednesday's Pre-Market Session
September 01, 2021
From Benzinga
What 9 Analyst Ratings Have To Say About ATAI Life Sciences
August 17, 2021
Tickers
ATAI
From Benzinga
From Benzinga
Psyched: Atai Launches 'Salvia Divinorum' Subsidiary, Mindset, Psilera and Wesana's Preclinical Trials, Origin Raises $5M
August 16, 2021
From Benzinga
Earnings Scheduled For August 16, 2021
August 16, 2021
From Benzinga
From Motley Fool
The Daily Biotech Pulse: Moderna's Vaccine Produces Durable Response Against Variants, FDA Approves Jazz's Sleep Disorder Drug, Dermata IPO
August 13, 2021
From Benzinga
Atai Life Sciences To Research Potent Psychedelic Herb Salvia Divinorum Through Its New Subsidiary
August 12, 2021
From Benzinga
The Daily Biotech Pulse: FDA Rejects FibroGen's Anemia Drug, Crinetics Gains On Positive Readout, BioCryst Withdraws Public Offering
August 11, 2021
From Benzinga
The Daily Biotech Pulse: Arcturus Soars On COVID-19 Vaccine Updates, Merck's Keytruda On Track For More Label Expansions, Eliem Debuts
August 10, 2021
From Benzinga
Stocks That Hit 52-Week Lows On Monday
August 09, 2021
From Benzinga
The Daily Biotech Pulse: Dicerna Slips On Data, Novavax Tightlipped On US Vaccine Approval, Adagio IPO
August 06, 2021
From Benzinga
Stocks That Hit 52-Week Lows On Thursday
August 05, 2021
From Benzinga
From Benzinga
Understanding ATAI Life Sciences's Unusual Options Activity
August 04, 2021
Tickers
ATAI
From Benzinga
Psyched: Field Trip Uplists To Nasdaq, MindMed To Study DMT, Atai Launches New Subsidiary, AOC's Psychedelics Amendment Rejected
August 02, 2021
From Benzinga
Atai Launches New "Nose-To-Brain" Drug Delivery Company To Interact With Its Portfolio Of Psychedelics Subsidiaries
July 28, 2021
Tickers
ATAI
From Benzinga
From Benzinga
From Benzinga
Field Trip Health Heads To The Nasdaq As Wall Street Opens Up To "Psychedelics Renaissance"
July 23, 2021
From Benzinga
Psyched: Investment Banks Bullish On Atai Life Sciences, Wesana's $17M Purchase Of PsyTech, Creso Pharma Acquires Halucenex
July 19, 2021
From Benzinga
From Benzinga
4 Green Flags for Psychedelic Drug Stocks
July 15, 2021
From Motley Fool
From Benzinga
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.